Correlation Between Sarepta Therapeutics and Amgen

Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarepta Therapeutics and Amgen Inc, you can compare the effects of market volatilities on Sarepta Therapeutics and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Amgen.

Diversification Opportunities for Sarepta Therapeutics and Amgen

-0.72

Correlation Coefficient

Sarepta Therapeutics  Amgen

Pay attention - limited upside

The 3 months correlation between Sarepta and Amgen is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Amgen go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and Amgen

Given the investment horizon of 90 days Sarepta Therapeutics is expected to under-perform the Amgen. In addition to that, Sarepta Therapeutics is 1.32 times more volatile than Amgen Inc. It trades about -0.17 of its total potential returns per unit of risk. Amgen Inc is currently generating about 0.13 per unit of volatility. If you would invest  27,609  in Amgen Inc on December 3, 2024 and sell it today you would earn a total of  3,368  from holding Amgen Inc or generate 12.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sarepta Therapeutics  vs.  Amgen Inc

Sarepta Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Amgen Inc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Amgen may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Sarepta Therapeutics and Amgen

The main advantage of trading using opposite Sarepta Therapeutics and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.

The idea behind Sarepta Therapeutics and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.